Lubiprostone
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 483 publications
Constipation with bloating: a clinical approach to evaluation and management.
Journal: Annals of medicine
Published: June 19, 2026
Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines.
Journal: Drug discoveries & therapeutics
Published: April 16, 2026
Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social Media and E-Forum Posts.
Journal: Neurogastroenterology and motility
Published: February 27, 2026
Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Efficacy of Tenapanor in Patients With or Without Prior Use of IBS-C Prescription Medications: A Post-hoc Analysis of Phase 3 Clinical Trials.
Journal: Digestive diseases and sciences
Published: December 15, 2025
Advances in the Treatment of Refractory Pediatric Constipation
Journal: Acta gastroenterologica Latinoamericana
Published: December 04, 2025
PGE1 Suppresses the Expression of M2 Markers on Macrophages Through Prostaglandin Receptors.
Journal: Cells
Published: December 01, 2025
Irritable Bowel Syndrome with Constipation: Diagnosis and Multisymptom Management Beyond Abdominal Pain and Bowel Movement Frequency: A Review.
Journal: Advances in therapy
Published: November 21, 2025
Laxative use and acute kidney injury risk: Analysis of a Japanese hospital-based database.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 15, 2025
Laxative logic: when lifestyle is not enough.
Journal: Current opinion in gastroenterology
Published: September 29, 2025
Beyond gluten-free diet: repurposing pitavastatin and lubiprostone as cathepsin S inhibitors for celiac disease therapy.
Journal: In silico pharmacology
Published: September 15, 2025
Last Updated: 11/08/2026